Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based studyKuniko Sunami, Takashi Kohno, Takafumi Koyama et al.|Cancer Science|2019Cited by 375
First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid TumorsToshio Shimizu, Noboru Yamamoto, Yutaka Fujiwara et al.|Clinical Cancer Research|2021Cited by 97
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung AdenocarcinomaHourin Cho, Hidehito Horinouchi, Kouya Shiraishi et al.|Journal of Thoracic Oncology|2025Cited by 6